☆ 4.7 Article

Assessment of Initial Depressive State and Pain Relief With Ketamine in Patients With Chronic Refractory Pain

JAMA NETWORK OPEN (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Neurosciences

The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression

Muhammad Youshay Jawad et al.

Summary: Ketamine has emerged as a novel and effective antidepressant, with the potential to improve various domains of depressive symptomatology. While its effectiveness in reducing depression severity is well-studied, more research is needed to explore its effects on cognition, anhedonia, suicidality, and psychosocial functionality. Findings suggest that ketamine is most effective in reducing suicidality but further studies are required to assess its effectiveness in other domains.

NEUROPHARMACOLOGY (2023)

添加到收藏夹

Article Neurosciences

Enhanced function of NR2C/2D-containing NMDA receptor in the nucleus accumbens contributes to peripheral nerve injury-induced neuropathic pain and depression in mice

Peng-Bo Jing et al.

Summary: NMDAR dysfunction in the NAc is involved in neurological and psychiatric disorders. This study demonstrates that the functional change of NR2C/2D subunits-containing NMDARs in the NAc may contribute to the sensory and affective components in neuropathic pain.

MOLECULAR PAIN (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials

Luca Sforzini et al.

Summary: The document discusses the criteria for treatment-resistant depression (TRD) and partially responsive depression (PRD) as subtypes of major depressive disorder (MDD) which are not clearly defined, using a Delphi-method-based consensus approach. It reviews literature and gathers international experts to evaluate controversies and provide recommendations on designing clinical trials and guiding research. It aims to support the design of a protocol for platform trials of new medications for TRD/PRD as part of the EUropean Patient-cEntric clinicAl tRial pLatforms, Innovative Medicines Initiative (EU-PEARL, IMI) MDD project.

MOLECULAR PSYCHIATRY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor

Yan Wei et al.

Summary: The discovery of antidepressant actions of (R,S)-ketamine has been a crucial breakthrough in mood disorder research. Esketamine nasal spray has been approved for treatment-resistant depression, but arketamine has shown greater potency and longer-lasting effects in rodents. Clinical trials have not replicated the robust antidepressant actions of ketamine-related compounds seen in rodents in human patients, highlighting the complexity of psychiatric disorders.

MOLECULAR PSYCHIATRY (2022)

添加到收藏夹

Article Clinical Neurology

Ketamine as a therapeutic agent for depression and pain: mechanisms and evidence

Subha Subramanian et al.

Summary: Ketamine, an anesthetic drug, is now being used to treat chronic pain conditions and psychiatric disorders, particularly depression. However, there is limited research on treating chronic pain and comorbid depression and pain with ketamine.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2022)

添加到收藏夹

Article Anesthesiology

Ketamine for refractory chronic pain: a 1-year follow-up study

Alexandrine Corriger et al.

Summary: Ketamine has a significant long-term effect on pain and health variables in patients with refractory chronic pain. Pain intensity decreased significantly, and distinct pain trajectories were identified. The severity of pain is associated with psychological health and quality of life.

PAIN (2022)

添加到收藏夹

Review Psychiatry

Neural correlates of co-occurring pain and depression: an activation-likelihood estimation (ALE) meta-analysis and systematic review

Carmen Jiamin Zheng et al.

Summary: The relationship between pain and depression is bidirectional and they share underlying neurobiology. However, there is a lack of quantitative studies on the neurobiology of pain-depression comorbidity, especially in addressing the direction of comorbidity. This systematic review used activation likelihood estimation (ALE) meta-analysis to identify brain correlates associated with different types of pain and depression comorbidity.

TRANSLATIONAL PSYCHIATRY (2022)

添加到收藏夹

Article Psychiatry

Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients

Xiaofeng Lan et al.

Summary: This study found that in depression patients with severe pain, significant improvement in depressive symptoms was observed after six ketamine infusions, while patients with mild pain or no pain showed lower improvement.

FRONTIERS IN PSYCHIATRY (2022)

添加到收藏夹

Article Psychiatry

Evaluation of Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression

Hugo Bottemanne et al.

Summary: This study investigates how ketamine alters belief updating and its association with clinical effects. The results reveal that patients with treatment-resistant depression show greater belief updating after receiving good news following a single ketamine infusion, suggesting the cognitive mechanisms underlying ketamine's action in these patients.

JAMA PSYCHIATRY (2022)

添加到收藏夹

Review Neurosciences

Targeting NMDA Receptors in Emotional Disorders: Their Role in Neuroprotection

Siqi Wang et al.

Summary: This review discusses the role of N-methyl-D-aspartate (NMDA) receptors in the pathophysiological processes of psychiatric mood disorders and analyzes their neuroprotective mechanisms. It first introduces the involvement of NMDA receptors in brain function and mood regulation, as well as their pathological mechanisms in disorders such as anxiety and depression. It then provides an in-depth summary of current NMDA receptor modulators and their potential application in the treatment of anxiety and depression. These findings suggest that targeting NMDA receptors with drugs may open up new possibilities for the treatment of refractory anxiety and depression.

BRAIN SCIENCES (2022)

添加到收藏夹

Review Clinical Neurology

Efficacy of ketamine for comorbid depression and acute or chronic pain: A systematic review

Aksharra Balachandran et al.

Summary: Sub-anesthetic doses of ketamine may be effective in treating individuals with comorbid depression and chronic pain (CDCP) as well as comorbid depression and acute pain (CDAP). However, the current review identified a small number of heterogeneous studies with mixed results, highlighting the need for more placebo-controlled studies to determine the effects of ketamine in this population.

FRONTIERS IN PAIN RESEARCH (2022)

添加到收藏夹

Review Medicine, General & Internal

Chronic Pain-Induced Depression: A Review of Prevalence and Management

Roja T. Meda et al.

Summary: This article discusses the prevalence of chronic pain and chronic pain-induced depression, along with methods of prevention. It also explores the molecular mechanisms underlying both conditions and reviews management methods that target these mechanisms. The article emphasizes the importance of awareness regarding chronic pain-induced depression for advancements in mental health.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

添加到收藏夹

Review Psychology, Clinical

The Effects of Ketamine on Cognition in Unipolar and Bipolar Depression: A Systematic Review

Sophie R. Vaccarino et al.

Summary: This study aimed to determine the neurocognitive effects of ketamine in MDD and BD patients. The results showed that there were no negative cognitive effects of single or repeated ketamine administration within 2 weeks in MDD patients, but there is limited data available for BD populations and other routes of ketamine administration.

JOURNAL OF CLINICAL PSYCHIATRY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals

Anahit Mkrtchian et al.

Summary: Ketamine improved motivational symptoms in patients with treatment-resistant major depressive disorder by normalizing fronto-striatal connectivity, while disrupting this connectivity in healthy volunteers, regardless of inflammatory processes.

MOLECULAR PSYCHIATRY (2021)

添加到收藏夹

Article Clinical Neurology

Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers

Torsten Passie et al.

Summary: Ketamine and its enantiomers, particularly the (S)-enantiomer, have distinct psychological effects which can impact psychopathology and neurocognitive function. While (R)-ketamine appears to have fewer dissociative and psychotomimetic effects at subanesthetic doses, (S)-ketamine may induce more negative psychopathology experiences. The study suggests that the ideal composition of ketamine for treating depression should include (R)-ketamine, as it may offer protective effects against negative psychotomimetic effects compared to (S)-ketamine.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)

添加到收藏夹

Review Behavioral Sciences

The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research

Hartej Gill et al.

Summary: Research suggests that intravenous ketamine may have positive effects on cognition in TRD patients, including improvements in working memory and visual learning memory, although symptoms in anxious TRD participants may show more significant improvement.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)

添加到收藏夹

Article Psychiatry

Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

Roger S. McIntyre et al.

Summary: Replicated international studies have highlighted the human and societal costs of major depressive disorder, with monoamine-based antidepressants proving effective but many patients failing to fully recover. Ketamine and esketamine offer novel pharmacological treatments for treatment-resistant depression, but questions remain about their safety and effectiveness. International experts provide guidance on the use of these agents, while discussing areas of consensus and future research directions.

AMERICAN JOURNAL OF PSYCHIATRY (2021)

添加到收藏夹

Article Immunology

Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine

Yanling Zhou et al.

Summary: The study showed that TRD patients with pain had a higher antidepressant response rate and remission rate compared to those without pain. Before treatment, inflammatory cytokine levels were higher in the pain group. Additionally, changes in inflammatory cytokines, particularly IL-6, were associated with improvements in pain intensity and depressive symptoms in the pain group.

JOURNAL OF NEUROINFLAMMATION (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Mechanisms of ketamine action as an antidepressant

P. Zanos et al.

MOLECULAR PSYCHIATRY (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Effect of ketamine combined with magnesium sulfate in neuropathic pain patients (KETAPAIN): study protocol for a randomized controlled trial

Noemie Delage et al.

TRIALS (2017)

添加到收藏夹

Review Neurosciences

The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain

Jiyao Sheng et al.

NEURAL PLASTICITY (2017)

添加到收藏夹

Article Clinical Neurology

Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial

Morteza Jafarinia et al.

JOURNAL OF AFFECTIVE DISORDERS (2016)

添加到收藏夹

Article Multidisciplinary Sciences

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Panos Zanos et al.

NATURE (2016)

添加到收藏夹

Article Anesthesiology

Depression in patients with chronic pain attending a specialised pain treatment centre: prevalence and impact on health care costs

Lauren Rayner et al.

PAIN (2016)

添加到收藏夹

Article Clinical Neurology

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

Nanna B. Finnerup et al.

LANCET NEUROLOGY (2015)

添加到收藏夹

Article Anesthesiology

Cognitive Function in Older Patients with Postherpetic Neuralgia

Gisele Pickering et al.

PAIN PRACTICE (2014)

添加到收藏夹

Editorial Material Anesthesiology

Depression and Pain Does Ketamine Improve the Quality of Life of Patients in Chronic Pain by Targeting Their Mood?

E. Alfonso Romero-Sandoval

ANESTHESIOLOGY (2011)

添加到收藏夹

Article Anesthesiology

A Single Subanesthetic Dose of Ketamine Relieves Depression-like Behaviors Induced by Neuropathic Pain in Rats

Jing Wang et al.

ANESTHESIOLOGY (2011)

添加到收藏夹

Article Clinical Neurology

Pain as a symptom of depression: Prevalence and clinical correlates in patients attending psychiatric clinics

L. Agueera-Ortiz et al.

JOURNAL OF AFFECTIVE DISORDERS (2011)

添加到收藏夹

Review Anesthesiology

Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations

Robert H. Dworkin et al.

PAIN (2010)

添加到收藏夹

Article Anesthesiology

The Adverse Effects of Comorbid Pain on Depression Outcomes in Primary Care Patients: Results from the Artist Trial

Angela M. DeVeaugh-Geiss et al.

PAIN MEDICINE (2010)

添加到收藏夹

Review Behavioral Sciences

Cognitive theory and therapy of anxiety and depression: Convergence with neurobiological findings

David A. Clark et al.

TRENDS IN COGNITIVE SCIENCES (2010)

添加到收藏夹

Review Anesthesiology

Ketamine for chronic non-cancer pain

Rae Frances Bell

PAIN (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.